Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as C$0.25 and last traded at C$0.23, with a volume of 270656 shares changing hands. The stock had previously closed at C$0.24.
Voyageur Pharmaceuticals Stock Performance
The company has a market cap of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32. The company’s fifty day moving average price is C$0.10 and its 200 day moving average price is C$0.07. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Pros And Cons Of Monthly Dividend Stocks
- Nebius Group: Market Overreaction or Real AI Disruption?
- The 3 Best Fintech Stocks to Buy Now
- The Best Way to Invest in Gold Is…
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
